Aditxt Signs Asset Purchase Agreement for 50% Ownership of Global Response Aid (Avigan) with Cellvera and Agility

Aditxt Enters Revenue-Sharing Agreement with Cellvera in Connection with Proposed Acquisition of Cellvera

April 5, 2022

Biotechnology

Aditxt, Inc. has entered into a revenue-sharing agreement with Cellvera Global Holdings LLC and certain affiliates to support Aditxt’s proposed acquisition of Cellvera. The agreement provides Aditxt with up to 10% of net sales (up to $30 million) while enhancing the security for Cellvera’s loan to Aditxt and extending the due diligence period for the overall transaction.

Aditxt Signs Share Exchange Agreement to Acquire AiPharma Global Holdings

December 28, 2021

Healthcare Services

Aditxt (Nasdaq: ADTX) signed a share exchange agreement to acquire AiPharma Global Holdings LLC (AiPharma Global) in a two-step transaction involving an initial closing and a secondary closing, subject to conditions including regulatory, board, shareholder, and Nasdaq approvals. The deal would give Aditxt 9.5% of AiPharma at the initial closing and the remaining 90.5% at the secondary closing, with cash payments and Aditxt share issuance at each step.

Eli Lilly Acquires Adverum Biotechnologies

December 9, 2025

Biotechnology

Eli Lilly and Company agreed to acquire Adverum Biotechnologies in a cash-and-contingent-value-rights tender offer for all outstanding shares. The total consideration is $3.56 per share in cash at closing plus a CVR that could pay up to $8.91 per share upon achievement of specified milestones, with the transaction expected to close in the fourth quarter of 2025.

Aditxt Acquires Appili Therapeutics

October 10, 2024

Healthcare Services

Aditxt, Inc. announced that Appili Therapeutics shareholders will vote on a proposed acquisition of all issued and outstanding shares of Appili through a plan of arrangement. Appili’s board recommended shareholders vote in favor, and Aditxt intends to use Appili’s infectious disease pipeline (including the FDA-approved LIKMEZ) to expand its reach in combating life-threatening infections and biodefense threats.

ADDvise Group AB Acquires Graham Medical Technologies (GraMedica)

September 15, 2021

Medical Devices

ADDvise Group AB has acquired all outstanding shares of Graham Medical Technologies, LLC (GraMedica) in a deal that closed on September 15, 2021. The purchase price is approximately USD 5.8 million (USD 4.0 million initial payment plus up to USD 1.8 million in earn-outs); GraMedica reported 2020 revenue of about USD 3.35 million and adjusted EBITDA of approximately USD 0.85 million. The acquisition is intended to broaden ADDvise's medical equipment and consumables portfolio and expand its geographic reach.

Aptiva Medical Acquires VeraMed Health

October 7, 2025

Healthcare Services

Aptiva Medical, a Greenleaf Ventures portfolio company, has completed the acquisition of VeraMed Health. The deal expands Aptiva’s national patient base, strengthens its referral and payor networks, and accelerates its growth in continuous glucose monitoring (CGM) distribution and home-delivery diabetes services.